Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Millimed Holdings acquires Cube Medical
Mandate

Millimed Holdings acquires Cube Medical

May 12, 2005

Millimed Holdings Inc., a newly established US holding company backed by ten Danish and international venture investment funds fronted by Advent International, has agreed to acquire Cube Medical A/S, a Denmark based research, development and production company within the area of vascular medical devices, and Millimed Vascular Intervention AB, a Sweden based sales and marketing company for vascular medical devices. The initial consideration of is USD 12m and an investment of USD 10m contingent upon the achievement of certain milestones.

Vinge acted for Millimed Holdings Inc.
Arne Källén (responsible partner)
Anna Jonsson (associate)

Related

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

 On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

 Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026

Vinge advises SenzaGen on its acquisition of Alcyomics

 SenzaGen AB (publ) has acquired Alcyomics Ltd. The transaction is being financed through a combination of existing cash and a directed issue of convertible bonds.
November 09, 2026